Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras - PubMed (original) (raw)

Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras

A B Glick et al. Mol Carcinog. 1991.

Abstract

The influence of an oncogenic v-Ha-ras gene on the expression of TGF-beta and TGF-alpha by mouse keratinocytes and derived tumors has been investigated. Normal mouse keratinocytes cultured as basal cells in 0.05 mM Ca2+ secreted low levels of TGF-beta 2 peptide, and this increased markedly following culture in 1.4 mM Ca2+, retinoic acid, or phorbol esters. In contrast, introduction of a v-Ha-ras gene into normal keratinocytes increased basal expression and secretion of TGF-beta 1 (rather than TGF-beta 2) in response to all three agents. The selective secretion of TGF-beta 1 in v-Ha-ras keratinocytes in response to 1.4 mM Ca2+ occurred even though the four TGF-beta 2 transcripts were induced and the TGF-beta 1 transcript decreased, suggesting that the activated v-Ha-ras gene product regulates expression of the TGF-beta isoforms at the posttranscriptional level. Immunohistochemical analysis of papillomas formed following skin grafting of v-Ha-ras keratinocytes onto nude mice indicated that TGF-beta 1 was abundant in the basal and spinous layers, while there was no expression of TGF-beta 1 in normal skin. In contrast, both normal and neoplastic tissues expressed TGF-beta 2 and TGF-beta 3 in the granular layers. Furthermore, TGF-alpha mRNA expression was also elevated fivefold in cultured v-Ha-ras keratinocytes, and TGF-alpha protein was overexpressed in the grafted papillomas, but there was no detectable expression in normal skin. Elevated expression of both TGF-beta 1 and TGF-alpha in the basal and spinous layers of benign tumors may be important for the high proliferation rate in these tumors as well as for increased proliferation in the suprabasal layer.

PubMed Disclaimer

Cited by

Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.
Cataisson C, Ohman R, Patel G, Pearson A, Tsien M, Jay S, Wright L, Hennings H, Yuspa SH. Cataisson C, et al. Cancer Res. 2009 Jan 1;69(1):319-28. doi: 10.1158/0008-5472.CAN-08-2490. Cancer Res. 2009. PMID: 19118017 Free PMC article.
Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis.
Vassar R, Hutton ME, Fuchs E. Vassar R, et al. Mol Cell Biol. 1992 Oct;12(10):4643-53. doi: 10.1128/mcb.12.10.4643-4653.1992. Mol Cell Biol. 1992. PMID: 1406654 Free PMC article.
The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck.
Clark LJ, Edington K, Swan IR, McLay KA, Newlands WJ, Wills LC, Young HA, Johnston PW, Mitchell R, Robertson G, et al. Clark LJ, et al. Br J Cancer. 1993 Sep;68(3):617-20. doi: 10.1038/bjc.1993.396. Br J Cancer. 1993. PMID: 8353052 Free PMC article.
Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.
Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S, Yuspa SH. Glick AB, et al. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6076-80. doi: 10.1073/pnas.90.13.6076. Proc Natl Acad Sci U S A. 1993. PMID: 7687059 Free PMC article.
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.
Danielpour D. Danielpour D. Pharmaceuticals (Basel). 2024 Apr 20;17(4):533. doi: 10.3390/ph17040533. Pharmaceuticals (Basel). 2024. PMID: 38675493 Free PMC article. Review.

Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras - PubMed (original) (raw)